End-of-day quote
Other stock markets
|
||
- USD | - |
14/05 | Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M | MT |
2023 | NovaBay to Commercialize BioStem's Amniotic Tissue Allograft | MT |
Managers | Title | Age | Since |
---|---|---|---|
Andrew van Vurst
FOU | Founder | - | 07/06/07 |
Chief Executive Officer | - | 07/06/07 | |
Director of Finance/CFO | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Dugan
CHM | Chairman | 66 | 13/12 |
Patrick Daly
BRD | Director/Board Member | - | 19/12 |
Chief Executive Officer | - | 07/06/07 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- Stock